Align Technology, Inc.

Healthcare · Medical - Devices

Overall research band Mixed

Quality Weak

Valuation Above average

Balance sheet Exceptional

Market confirmation Very weak

One-minute company read

What this report can tell you now

What the company does

Align Technology, Inc. is a medical technology company that develops, manufactures, and markets Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. Its operations are organized into two segments: Clear Aligner, which offers comprehensive and non-comprehensive Invisalign treatments for various age groups and orthodontic needs, as well as retention devices and ancillary products; and Scanners and Services, which provides iTero scanners, specialized software for restorative and orthodontic procedures, CAD/CAM services, and related accessories. Align Technology serves dental professionals such as orthodontists, general dentists, prosthodontists, periodontists, and oral surgeons, generating revenue through the sale of its products, software, and associated services worldwide.

The current research profile is Balanced Opportunity, with balance-sheet strength. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

No single strength should be treated as decisive without reviewing the underlying evidence and data status.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC14.4%Model input; read with the evidence status and period context.

Operating margin15.3%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years0.5%Model input; read with the evidence status and period context.

FCF margin12.2%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.